SCI Cancer Innovation Award

2021 Spring Innovation Awardees

SCI Cancer Innovation Award

  • “A Multi-tiered Genomic and Transcriptomic Predictor of Response to Immunotherapy in Sarcomas” Nam Bui, MD (Everett Moding, MD, PhD)
  • “Which Men Benefit From Prostate Cancer Screening? A Machine Learning-Enhanced Regression Discontinuity Analysis to Identify Heterogeneous Treatment Effects in Stanford's and National Cancer Patient Cohorts” Tina Hernandez-Boussard, MD, PhD
  • “A Novel Approach to Enhance the Potency and Specificity of CAR T Cells for Solid Tumors” Robbie Majzner, MD

SCI Pancreatic Cancer Innovation Award

  • “A Conceptually New Approach to NET-Targeted Chemotherapeutic Delivery” Justin Annes, MD, PhD
  • “Targeting Pancreatic Cancer with ALDH1B1 Antagonists” James Chen, PhD
  • “Synthetic-Circuit-Mediated Immunotherapy Against KRAS-Driven Pancreatic Cancer” Xiaojing Gao, PhD
  • “Deciphering the Impact of Neoadjuvant Chemotherapy on the Antitumor Immunity and Antibody Delivery in Pancreatic Cancer Patients Using Single-Cell Spatial Mapping” George Poultside, MD (George Fisher, MD)

Stanford Women’s Cancer Center Innovation Award

  • "Comprehensive Molecular Profiling of Primary Angiosarcomas and Hemangiomas of the Breast to Aide in Diagnosis and Treatment" Gregory Bean, MD, PhD
  • "Preclinical Model for Evaluating FLASH Radiotherapy for Breast Cancer” Frederick Dirbas, MD (Ted Graves, PhD; Kathleen Horst, MD; Bill Loo, MD, PhD)
  • “Differential Compartmentalization of the Actin-Binding Protein CapG Increases Breast and Ovarian Cancer Cell Invasiveness” Oliver Dorigo, MD, PhD
  • "Revealing the Potential for mSWI/SNF as Biomarkers in Breast Cancers"  Capucine Van Rechem, PhD

SCI Nodal Grant Award

  • “Impact of COVID-19 on Cancer-Directed Management and Outcomes.” Sumit Shah, MD, PhD
  • “Determining and Targeting Mechanisms Controlling Cancer Cell Division” Jan Skotheim, PhD (Julien Sage, PhD)


SCI Innovation Awards celebrate the dedication of some of Stanford’s most innovative thinkers.  By supporting the novel ideas and groundbreaking work of the awardees, either as individual or group awards, the SCI enhances investigator potential to find solutions that will alter the future of cancer research and patient care.  Since 2006, the SCI has provided over $13M in research related award funding.

Proposal Submission Deadline: October 20, 2021